By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Painless Injections Make Child Vaccine Delivery Easy
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Painless Injections Make Child Vaccine Delivery Easy
Medical DevicesPublic HealthTechnology

Painless Injections Make Child Vaccine Delivery Easy

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

AtriCure (NASDAQ:ATRC) founder, Michael Hooven‘s next project could change the way children are injected with vaccines. Hooven politely declined to provide much detail on Cincinnati-based Enable Injections, saying that the company is still in its very early stages — though that could be changing soon. “In general, there are some very exciting developments we expect to see in the next few months with Enable Injections,” he said, choosing not to give any hints on what those exciting developments might be. Hooven did allow that the company’s technology was developed at Cincinnati Children’s Hospital Medical Center, and that Enable has received funding from the hospital and state-backed venture development group CincyTech. While not a lot of specifics about Enable are known, Hooven has publicly discussed the broad outlines of his plans for the company. Last year, he told Hi Velocity Media that Enable is developing a painless injection for children’s vaccines and aims to pioneer a safer, faster and lower-cost drug-injection technology. “The days of the big, scary needles are coming to an end,” he said. A longtime medical device veteran with a background in physics and mechanical engineering, Hooven started working with Cordis and Cincinnati’s Ethicon Endo-Surgery (both since acquired by Johnson & Johnson) in the 1980s. He went on to found cardiac surgical device maker AtriCure, which went public in 2005 and is working to develop a “hybrid” approach to treating atrial fibrillation that it says holds a market potential of $2 billion. In the world of startups, success often breeds success, so Hooven’s accomplishments with AtriCure will clearly serve him well as he tries to grow Enable. “He’s now got the kind of reputation where he can to go the big West Coast VCs and they know who he is and they’ll back him,” said Rick D’Augustine, an executive in residence with CincyTech who’s known Hooven for about 20 years since they worked together at Ethicon Endo-Surgery. “We don’t have too many guys like that in Cincinnati.” D’Augustine was also reluctant to provide much detail of the technology Enable is developing. “It’s just taking a different approach to how you deliver any kind of therapeutic with an injection,” he said. CincyTech has been working with Hooven to identify markets for the technology beyond children’s vaccinations, plus opportunities for nondilutive grant funding. D’Augustine has an insight into Enable’s technology that few others do — he allowed Hooven to use a prototype of the device on him. “I had this thing in my arm and it felt like someone had pinched me,” he said. That experience, plus his history with Hooven, have D’Augustine feeling confident that Enable’s future is bright. “What Mike is great at — he’s one of the best I’ve ever worked with – is coming up with a simple, elegant and cost-effective solution to a unique problem,” D’Augustine said. Innova Medical Design, another development stage company, has designed an effective and pragmatic solution to alleviate needle pain associated with blood draws, IV starts, injections, vaccinations and lancet piercing. Prototypes have been produced and successfully tested in 2009. New product development is underway to address needle and lancet pain for diabetic patients. Innova is located in Minneapolis, MN. Source

TAGGED:medical technologypublic healthvaccinations
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

New Blood Test Could Help Doctors Figure Out Origins of Strokes

January 27, 2014
Medical DevicesPublic Health

Is The Future Of Injectable Drug Delivery In Needle-Free Devices?

January 28, 2019
rare disease communities
Policy & LawPublic HealthSpecialties

Geolocating a Cure for a Rare Disease

August 5, 2013

Cell Matrices in Tissue Engineering

September 8, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?